Ameriprise Financial (AMP) Announces Positive Results from OptimEyes DME Trial
Tweet Send to a Friend
Ameriprise Financial (NYSE: AMP) announced positive results of the OptimEyes trial for DME. The OptimEyes trial was a multiple site ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
